Prices per Course | NOTE: ACLM members receive an exclusive 20% discount.
Nonmember - $50
Member - $40
1 CME/CNE/CE Credit
0 CPE Credits
(Full Accreditation information listed below)
This session will highlight the new, and first, multidisciplinary Expert Consensus Statement (ECS) developed by the American College of Lifestyle Medicine (ACLM) on Dietary Interventions to Treat Type 2 Diabetes (T2D) in Adults with a Goal of Remission. The objective of the ECS is help clinicians achieve remission of type 2 diabetes (T2D) in adults using diet as a primary intervention, by providing evidence-informed statements agreed upon by experts from the American College of Lifestyle Medicine, American Association of Clinical Endocrinology (AACE), American Academy of Family Physicians (AAFP), American College of Cardiology (ACC), American Heart Association (AHA), Academy of Nutrition and Dietetics (AND), and the Endocrine Society (ES). Using a valid and trustworthy process, which included iterative Delphi surveys, the panel reached consensus on 68 statements related to definitions, diet as a primary intervention for remission of T2D, dietary specifics, adjuvant interventions, monitoring therapy, weight loss, and payment and policy. Clinicians can use these statements to improve quality of care, inform policy and protocols and to identify areas of uncertainty.
- Describe the process for creating a valid and trustworthy expert consensus statement
- Define remission for T2D in adults based on minimum time and glycemic measures
- Discuss how to apply the expert consensus statements in practice to achieve remission in many adults with T2D by using diet as a primary intervention
- Discuss implications of the ECS for clinical practice, future research, and health policy
John Kelly, MD, MPH, LM Specialist | President, Oak Haven Lifestyle Medicine
Dr. Kelly is trained in Biochemistry, Molecular Biology, Medicine, Epidemiology and Information Technology (IT). He completed studies at Loma Linda University in Preventive and Lifestyle Medicine and has done funded research in Lifestyle Medicine, was founding President of ACLM, co-author of the Board Review Course in LM, and founding Chair for the Expert LM Panel. He received the AMA excellence in medicine award in 2004 for his work in establishing the American College of Lifestyle Medicine. He practices and teaches LM using a residential CHIP program in Pullman, Michigan where he serves as President for Oak Haven Country Life Natural Foods and Medical Director for the Oak Haven LM Training Center. Dr. Kelly has established a lifestyle medicine fellowship program, and serves as adjunct faculty at two medical schools.
Micaela Karlsen, PhD, MSPH | Director - Lifestyle Medicine Economic Research Consortium, American College of Lifestyle Medicine
Micaela Karlsen, PhD, MSPH serves as Director of the Lifestyle Medicine Economic Research Consortium for the American College of Lifestyle Medicine and the Lifestyle Medicine Institute, as a member of the Lifestyle Medicine Expert Panel, and as co-investigator on the Adhering to Dietary Approaches for Personal Taste (ADAPT) Study from Tufts University. She is Adjunct Faculty for the University of New England Master’ Programs in Applied Nutrition and Global Public Health. Dr. Karlsen is the author of A Plant-Based Life and a contributor to the New York Times bestseller Forks Over Knives: The Plant-Based Way to Health. She created and maintains PlantBasedResearch.org, an online library of original, peer-reviewed research studies relevant to plant-based nutrition, as well as SustainableDiet.com, a 3-month transition program for supporting successful and permanent transitions to plant-based diets. Her expertise is in dietary patterns, plant-based nutrition and nutritional adequacy, and predictors of successful behavior change. She holds a PhD in Nutritional Epidemiology from the Tufts Friedman School of Nutrition Science and Policy and a Masters degree in Human Nutrition from the Johns Hopkins School of Public Health. She lives in Ithaca, NY with her husband and her two children.
Richard Rosenfeld, MD, MPH, MBA, DipABLM | Distinguished Professor and Chairman of Otolaryngology, SUNY Downstate Health Sciences University
Richard Rosenfeld, MD, MPH, MBA is Distinguished Professor, Residency Program Director, and Chairman of Otolaryngology at SUNY Downstate Health Sciences University, in Brooklyn, New York. He is Board Certified in Lifestyle Medicine, follows a whole food, plant-based diet, runs marathons, and enjoys regular weight training. Dr. Rosenfeld is on the ACLM Research Committee and Expert Panel and chairs the Expert Consensus Panel on dietary intervention for type 2 diabetes remission. He founded the Downstate Committee on Plant-based Health & Nutritionto promote plant-based eating and is faculty advisor to the medical student Lifestyle Medicine Interest Group and Downstate Initiative for Nutritional Empowerment club . Dr. Rosenfeld received the Distinguished Service Award five times from the American Academy of Otolaryngology – Head and Neck Surgery, where he currently services as Senior Advisor for Guidelines and Quality. Dr. Rosenfeld has been listed every year since 1996 as one of “America’s Best Doctors” by Castle Connolly. He will serve on the Board of Directors for the American Board of Lifestyle Medicine beginning in November 2021.
Monica Agarwal, MD, MEHP, FACE | Associate Professor - Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham
Dr. Agarwal is an endocrinologist and obesity medicine specialist and Program Director of the UAB Obesity Medicine Fellowship Program. She is board certified in internal medicine, endocrinology, and obesity medicine. She did her Master of Medicine Education in Health Professions from Johns Hopkins School of Education.
She is an Associate Professor in Medicine at the University of Alabama in Birmingham(UAB). She is the parenteral nutrition specialist at the Birmingham VA medical center. She has served on several regional and national committees at the American Association of Clinical Endocrinology (AACE), The Obesity Society (TOS), the American Society of Nutrition (ASN), and the American Society of parenteral and enteral nutrition (ASPEN).
LM2021 OnDemand sessions are hosted online via the ACLM Learning Management System and each session consists of a title, description, learning objectives, speaker information, video recording, presentation slides in PDF format, an assessment and survey evaluation.
Assessment and Measurement
A score of 80% or higher on the module quiz is required to pass the course.
This content can be viewed on a desktop, tablet or mobile device. Speakers or headphones are required.
Term of Approval
July 1, 2022 – July 1, 2025
Access to online material is granted through the term of approval which ends July 1, 2025.
In support of patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.
This activity is being presented without bias and without commercial support.
Rush University Medical Center designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Rush University Medical Center designates this internet enduring material for a maximum of 1.0 nursing contact hour.
Rush University Medical Center designates this activity for 1.0 CE credits in psychology.
This activity has been approved by the Commission on Dietetic Registration for 1.0 CPEUs.
Rush University is an approved provider for physical therapy (216.000272), occupational therapy, respiratory therapy, social work (159.001203), nutrition, speech-audiology, and psychology by the Illinois Department of Professional Regulation.
Rush University designates this live/internet enduring material/enduring material activity for a maximum of 1.0 continuing education credits for physical therapists, occupational therapists, respiratory therapists, social workers, nutritionists, speech pathologists, audiologists, and/or psychologists.
The American Board of Lifestyle Medicine has approved 1.0 maintenance of certification credits for this learning activity.
The AAFP has reviewed LM2021 On Demand: Patient-Centered. Value Based. Outcome Drive. Virtual Conference and deemed it acceptable for AAFP Prescribed credit. Term of Approval is from 07/01/2022 to 07/01/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session: 1.0 Enduring Materials, Self-Study AAFP Prescribed Credit - ACLM Expert Consensus Statement: Dietary Interventions for Type 2 Diabetes Remission.
As a provider of continuing education, Rush University Medical Center asks everyone who has the ability to control or influence the content of an educational activity to disclose information about all of their financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, with ineligible companies. Individuals must disclose regardless of their view of the relevance of the relationship to the education. Mechanisms are in place to identify and mitigate any potential conflicts of interest prior to the start of the activity. All information disclosed must be shared with the participants/learners prior to the start of the educational activity.
Unapproved Uses of Drugs/Devices: In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.
The course directors, planners, faculty, and reviewers of this activity have no relevant financial relationships with ineligible companies to disclose.